For the first time in 20 years, a drug for the treatment of sickle cell disease has been approved in the United Kingdom.
The medicine is expected to reduce the times a patient would need to go to hospital for a crisis by almost half.
But as welcome as the drug may be to millions of sufferers around the world, including here in Nigeria, there are still some barriers.
Arise Correspondent Adefemi Akinsanya reports…
[bc_video video_id=”6275821977001″ account_id=”6116119081001″ player_id=”default” embed=”in-page” padding_top=”56%” autoplay=”” min_width=”0px” playsinline=”” picture_in_picture=”” max_width=”640px” mute=”” width=”100%” height=”100%” ]
Follow us on:
Gbadebo Rhodes-Vivour has condemned the commercialisation of GMO seeds, warning of threats to Nigeria’s food…
Oleksandr Usyk has secured victory over Tyson Fury in Riyadh, successfully defending his heavyweight championship…
Albania plans a one-year TikTok ban from January after a schoolboy’s death sparks concerns over…
A suspect accused of killing five people by driving into a crowded Christmas market in…
A US Navy F/A-18 Hornet was mistakenly shot down over the Red Sea by the…
NNPC has reduced petrol ex-depot price to N899 per litre, sparking competition with Dangote Refinery…